Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

Anja Eberl, Saara Huoponen, Tapio Pahikkala, Marja Blom, Perttu Arkkila, Taina Sipponen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume52
Issue number12
Pages (from-to)1348-1353
Number of pages6
ISSN0036-5521
DOIs
Publication statusPublished - 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Infliximab
  • biosimilar
  • CT-P13
  • Crohn's disease
  • ulcerative colitis
  • trough levels
  • TNF- antagonist
  • ULCERATIVE-COLITIS
  • CROHNS-DISEASE
  • DOUBLE-BLIND
  • INNOVATOR INFLIXIMAB
  • PARALLEL-GROUP
  • EFFICACY
  • SAFETY
  • MULTICENTER
  • ANTIBODIES
  • 3121 Internal medicine

Cite this

@article{49da1df4fcea409d94fc8fb77c6e4258,
title = "Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients",
keywords = "Infliximab, biosimilar, CT-P13, Crohn's disease, ulcerative colitis, trough levels, TNF- antagonist, ULCERATIVE-COLITIS, CROHNS-DISEASE, DOUBLE-BLIND, INNOVATOR INFLIXIMAB, PARALLEL-GROUP, EFFICACY, SAFETY, MULTICENTER, ANTIBODIES, 3121 Internal medicine",
author = "Anja Eberl and Saara Huoponen and Tapio Pahikkala and Marja Blom and Perttu Arkkila and Taina Sipponen",
year = "2017",
doi = "10.1080/00365521.2017.1369561",
language = "English",
volume = "52",
pages = "1348--1353",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "TAYLOR & FRANCIS LTD",
number = "12",

}

Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients. / Eberl, Anja; Huoponen, Saara; Pahikkala, Tapio; Blom, Marja; Arkkila, Perttu; Sipponen, Taina.

In: Scandinavian Journal of Gastroenterology, Vol. 52, No. 12, 2017, p. 1348-1353.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients

AU - Eberl, Anja

AU - Huoponen, Saara

AU - Pahikkala, Tapio

AU - Blom, Marja

AU - Arkkila, Perttu

AU - Sipponen, Taina

PY - 2017

Y1 - 2017

KW - Infliximab

KW - biosimilar

KW - CT-P13

KW - Crohn's disease

KW - ulcerative colitis

KW - trough levels

KW - TNF- antagonist

KW - ULCERATIVE-COLITIS

KW - CROHNS-DISEASE

KW - DOUBLE-BLIND

KW - INNOVATOR INFLIXIMAB

KW - PARALLEL-GROUP

KW - EFFICACY

KW - SAFETY

KW - MULTICENTER

KW - ANTIBODIES

KW - 3121 Internal medicine

U2 - 10.1080/00365521.2017.1369561

DO - 10.1080/00365521.2017.1369561

M3 - Article

VL - 52

SP - 1348

EP - 1353

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 12

ER -